http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-94007471-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e34ed063232fca5ab7e940a34d0b8989 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_018460f261c6c370b0846603d31ecef3 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00 |
filingDate | 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59065c997f22b9b5b2cfe3155fb22b9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c62e882f20b860cc5752bc26132869ac |
publicationDate | 1996-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-94007471-A |
titleOfInvention | Method of mastopathy treatment |
abstract | The invention relates to medicine and can be used in the treatment of diffuse estrogen-dependent mastopathy. The main objective of the invention is to eliminate the side effects of the drug and reduce the treatment of mastopathy. The problem is solved in that in the method of treating mastopathy, including the introduction of tamoxifen, tamoxifen in an amount of 0.5-3.0 wt.% Is introduced into the ointment base, which is close to the skin fat in water-fat balance, applied directly to the mammary gland and exposed the action of a magnetic field for 10-20 minutes, and the procedure is repeated 4-8 times with an interval of a day. The proposed method for the treatment of mastopathy contributes to the rapid stabilization of the process (5-7 days against 84), eliminates surgical intervention and the side effect of the drug on the body. |
priorityDate | 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535085 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 |
Total number of triples: 14.